6-OHDA induces cycle reentry and apoptosis of PC12 cells through activation of ERK1/2 signaling pathway

Abstract

This study investigated the effect and mechanism of cell cycle reentry induced by 6-hydrodopamine (6-OHDA) in PC12 cells. By using neural differentiated PC12 cells treated with 6-OHDA, the apoptosis model of dopaminergic neurons was established. Cell viability was measured by MTT. Cell apoptosis and the distribution of cell cycle were assessed by flow cytometry. Western blot was used to detect the activation of extracellular regulator kinase1/2 (ERK1/2) pathway and the phosphorylation of retinoblastoma protein (RB). Our results showed that after PC12 cells were treated wtih 6-OHDA, the viability of PC12 cells was declined in a concentration-dependent manner. Flow cytometry revealed that 6-OHDA could increase the apoptosis ratio of PC12 cells in a time-dependent manner. The percentage of cells in G0/G1 phase of cell cycle was decreased and that in S phase and G2/M phase increased. Simultaneously, ERK1/2 pathway was activated and phosphorylated RB increased. It was concluded that 6-OHDA could induce cell cycle reentry of dopaminergic neurons through the activation of ERK1/2 pathway and RB phosphorylation. The aberrant cell cycle reentry contributes to the apoptosis of dopaminergic neurons.

Keywords

6-hydrodopamine / cell cycle / extracellular regulator kinase1/2 / retinoblastoma protein / Parkinson’s disease

References

[1] SchulzJ.B.. Update on the pathogenesis of Parkinson’s disease. J Neurol, 2008, 255(Suppl5): S3-S7

[2] HerrupK., YangY.. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?. Nat Rev Neurosci, 2007, 8(5): 368-378

[3] WhiteL.R., ToftM., KvamS.N., et al. . MAPK-pathway activity, Lrrk2 G2019S, and Parkinson’s disease. J Neurosci Res, 2007, 85(6): 1288-1294

[4] BeckerE.B., BonniA.. Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol, 2004, 72(1): 1-25

[5] YangY., GeldmacherD.S., HerrupK.. DNA replication precedes neuronal cell death in Alzheimer’s disease. J Neurosci, 2001, 21(8): 2661-2668

[6] SimolaN., MorelliM., CartaA.R.. The 6-hydroxydopamine model of Parkinson’s disease. Neurotox Res, 2007, 11(3–4): 151-167

[7] BlandiniF., ArmenteroM.T., MartignoniE.. The 6-hydroxydopamine model: news from the past. Parkinsonism Relat Disord, 2008, 14(Suppl2): S124-S129

[8] VaudryD., StorkP.J., LazaroviciP., et al. . Signaling pathways for PC12 cell differentiation: making the right connections. Science, 2002, 296(5573): 1648-1649

[9] GreeneL.A., BiswasS.C., LiuD.X.. Cell cycle molecules and vertebrate neuron death: E2F at the hub. Cell Death Differ, 2004, 11(1): 49-60

[10] YangY., HerrupK.. Cell division in the CNS: protective response or lethal event in post-mitotic neurons?. Biochim Biophys Acta, 2007, 1772(4): 457-466

[11] RideoutH.J., WangQ., ParkD.S., et al. . Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition. J Neurosci, 2003, 23(4): 1237-1245

[12] AlviraD., TajesM., VerdaguerE., et al. . Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons. Neuroscience, 2007, 146(1): 350-365

[13] WangF., CorbettD., OsugaH., et al. . Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat. J Cereb Blood Flow Metab, 2002, 22(2): 171-182

[14] HerrupK., NeveR., AckermanS.L., et al. . Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci, 2004, 24(42): 9232-9239

[15] PolagerS., GinsbergD.. E2F — at the crossroads of life and death. Trends Cell Biol, 2008, 18(11): 528-535

[16] HoglingerG.U., BreunigJ.J., DepboyluC., et al. . The pRb/E2F cell-cycle pathway mediates cell death in Parkinson’s disease. Proc Natl Acad Sci U S A, 2007, 104(9): 3585-3590

[17] KhidrL., ChenP.L.. RB, the conductor that orchestrates life, death and differentiation. Oncogene, 2006, 25(38): 5210-5219

[18] ChuC.T., LevinthalD.J., KulichS.M., et al. . Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem, 2004, 271(11): 2060-2066

[19] ZhuJ.H., GuoF., ShelburneJ., et al. . Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol, 2003, 13(4): 473-481

[20] KulichS.M., HorbinskiC., PatelM., et al. . 6-Hydroxydo-pamine induces mitochondrial ERK activation. Free Radic Biol Med, 2007, 43(3): 372-383